
Corona Remedies Ltd is Rated Buy by MarketsMOJO
2026-11-22 10:10:06Corona Remedies Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 19 October 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 22 November 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read MoreCorona Remedies Ltd Falls 4.56% Despite All-Time High: 2 Key Factors Driving the Week
2026-11-14 09:01:12Key Events This Week 09 Nov: New 52-week high at Rs.2,659 and all-time high at Rs.2,577.50 11 Nov: Sharp decline of 7.00% on heavy volume 12 Nov: Continued modest decline of 0.80% 13 Nov: Week closes at Rs.2,327.75, down 4.56% for the week Week OpenRs.2,438.85 Week CloseRs.2,327.75<div cl...
Read More
Broad-Based Technical Strength Lifts Corona Remedies Ltd to 52-Week High of Rs 2659
2026-11-09 10:13:26With a decisive break above its previous highs, Corona Remedies Ltd surged to a fresh 52-week peak of Rs 2659 on 09 Nov 2026, propelled by a confluence of bullish technical indicators and sustained price momentum.
Read MoreCorona Remedies Surges 13.64%: 7 Key Factors Driving This Week’s Rally
2026-11-07 09:02:07Key Events This Week Nov 2: Stock opens at Rs.2,171.45 with a 1.18% gain Nov 3: New 52-week high at Rs.2,285 and technical momentum shift Nov 4: All-time high reached at Rs.2,349.7 and bullish technical upgrade Nov 5: Minor dip of 0.74% amid strong Sensex rally Nov 6: New 52-week and all-time high at Rs.2,485.6, closing at Rs.2,438.85 Week OpenRs.2,146.05</d...
Read More
Broad-Based Technical Strength Lifts Corona Remedies Ltd to 52-Week High of Rs 2485.6
2026-11-06 10:44:26Surging to an all-time high of Rs 2485.6 on 6 Nov 2026, Corona Remedies Ltd has demonstrated remarkable price momentum, breaking through multiple resistance levels amid a broadly positive market backdrop.
Read More
Broad-Based Technical Strength Lifts Corona Remedies Ltd to 52-Week High of Rs 2349.7
2026-11-04 10:02:00With a decisive surge to Rs 2349.7 on 4 Nov 2026, Corona Remedies Ltd has reached a fresh 52-week and all-time high, propelled by a confluence of bullish technical indicators and sustained price momentum.
Read More
Corona Remedies Ltd Hits All-Time High of Rs 2,302 as Momentum Builds Across Timeframes
2026-11-04 09:36:59Extending its winning streak to three sessions, Corona Remedies Ltd touched a fresh all-time high of Rs 2,302 on 4 Nov 2026, outperforming its sector and the broader market. The stock’s recent surge has been supported by strong technical momentum and robust quarterly financials, though valuation multiples suggest a cautious approach may be prudent.
Read MoreAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
16-Nov-2026 | Source : BSEIntimation of Participation in Analyst / Investor Conference
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
07-Nov-2026 | Source : BSEIntimation of Participation in Analyst / Investor Conference
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
05-Nov-2026 | Source : BSETranscript of Earnings Call with Analyst / Investor on Unaudited Financial Results for the second quarter and half year ended September 30 2026
Corporate Actions
No Upcoming Board Meetings
Corona Remedies Ltd has declared 100% dividend, ex-date: 19 Jun 26
No Splits history available
No Bonus history available
No Rights history available

